Chardan Capital Reaffirms Their Buy Rating on Oculis Holding (OCS)
Chardan Capital analyst Daniil Gataulin maintained a Buy rating on Oculis Holding today and set a price target of $51.00. The company’s shares closed yesterday at $19.06.Elevate Your Investing Strategy:...
Oculis Advances Privosegtor into Registrational Trials for Neuro-Ophthalmology
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Oculis Holding...
Oculis Holding (OCS) Gets a Buy from Bank of America Securities
In a report released today, Jason Gerberry from Bank of America Securities maintained a Buy rating on Oculis Holding, with a price target of $30.00. The company’s shares opened today at $17.86.Elevate...
Housing, Investment Numbers Due Next Week in Canada
U.S. Monday Economic Lookahead U.S. retail sales (Feb.) Empire State manufacturing ...